Announcement on Abnormal Fluctuations in Stock Trading
Filed with SSE · · 3 pages · Chinese
Summary by 6ix AI
The company reported that its stock price increased significantly over three consecutive trading days, which qualifies as abnormal trading activity according to exchange rules. The company confirmed that its business operations are normal and there are no undisclosed significant matters affecting the stock price. Investors are advised to be cautious and make informed decisions due to the recent volatility in stock prices.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
On 6ix: 6ix.com/news/shanghai-no1-pharmacy-co-ltdannouncement-on-abnormal-fluctuations-in-stock-trading
Shanghai No. 1 Pharmacy Co. Ltd. on 6ix
Earlier from Shanghai No. 1 Pharmacy
- Semi-annual Performance Forecast for 2026
- Announcement on Implementation of Dividend Distribution for 2025
- Announcement on Outline of the Performance Briefing for 2025 and Q1 2026
- Announcement on Convening Performance Briefing for 2025 and Q1 2026
- Announcement on Operating Data for Q1 2026
Later from Shanghai No. 1 Pharmacy
- Announcement on Change in Accounting Policies
- (600833)"Shanghai No.1 Pharmacy Co., Ltd."Announcement on Convening the 2026 Semi-annual Performance Briefing
- (600833)"Shanghai No.1 Pharmacy Co., Ltd."Announcement on Outline of the 2026 Semi-annual Performance Briefing
- (600833)"Shanghai No.1 Pharmacy Co., Ltd."Announcement on Change of Signing Certified Public Accountant and Quality Control Reviewer
- (600833)"Shanghai No.1 Pharmacy Co., Ltd."Announcement on Operating Data for Q3 2026
Follow Shanghai No. 1 Pharmacy into a list and get an email when it puts out news.
Follow Shanghai No. 1 Pharmacy